HSBC Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24M | Buy |
856,500
+267,900
| +46% | +$7.13M | 0.01% | 694 |
|
|
2025
Q4 | $14.7M | Buy |
+588,600
| New | +$14.8M | 0.01% | 842 |
|
|
2023
Q2 | – | Sell |
-20,000
| Closed | -$808K | – | 2702 |
|
|
2023
Q1 | $808K | Sell |
20,000
-30,000
| -60% | -$1.3M | ﹤0.01% | 1864 |
|
|
2022
Q4 | $2.56M | Hold |
50,000
| – | – | ﹤0.01% | 1570 |
|
|
2022
Q3 | $2.19M | Sell |
50,000
-30,000
| -38% | -$1.46M | ﹤0.01% | 1526 |
|
|
2022
Q2 | $4.08M | Sell |
80,000
-5,000
| -6% | -$255K | 0.01% | 1281 |
|
|
2022
Q1 | $4.4M | Sell |
85,000
-43,300
| -34% | -$2.25M | 0.01% | 1232 |
|
|
2021
Q4 | $7.58M | Buy |
128,300
+123,300
| +2,466% | +$6.11M | 0.01% | 1091 |
|
|
2021
Q3 | $215K | Buy |
+5,000
| New | +$222K | ﹤0.01% | 2750 |
|
|
2021
Q2 | – | Sell |
-7,000
| Closed | -$254K | – | 3040 |
|
|
2021
Q1 | $254K | Buy |
7,000
+6,000
| +600% | +$213K | ﹤0.01% | 2407 |
|
|
2020
Q4 | $39K | Sell |
1,000
-54,757
| -98% | -$2.01M | ﹤0.01% | 2997 |
|
|
2020
Q3 | $1.95M | Sell |
55,757
-5,270
| -9% | -$185K | ﹤0.01% | 1286 |
|
|
2020
Q2 | $1.89M | Sell |
61,027
-7,378
| -11% | -$251K | ﹤0.01% | 1185 |
|
|
2020
Q1 | $2.12M | Sell |
68,405
-234,515
| -77% | -$7.99M | ﹤0.01% | 1152 |
|
|
2019
Q4 | $11.2M | Sell |
302,920
-595,615
| -66% | -$21.2M | 0.02% | 776 |
|
|
2019
Q3 | $30.6M | Buy |
898,535
+458,490
| +104% | +$16.7M | 0.06% | 366 |
|
|
2019
Q2 | $18.1M | Sell |
440,045
-63,662
| -13% | -$2.53M | 0.03% | 546 |
|
|
2019
Q1 | $20.3M | Sell |
503,707
-1,053,894
| -68% | -$42.2M | 0.04% | 508 |
|
|
2018
Q4 | $64.5M | Buy |
1,557,601
+233,988
| +18% | +$9.71M | 0.12% | 168 |
|
|
2018
Q3 | $55.3M | Buy |
1,323,613
+141,974
| +12% | +$5.47M | 0.09% | 222 |
|
|
2018
Q2 | $40.7M | Buy |
1,181,639
+38,471
| +3% | +$1.31M | 0.07% | 266 |
|
|
2018
Q1 | $38.5M | Buy |
1,143,168
+1,136,844
| +17,977% | +$39.1M | 0.06% | 316 |
|
|
2017
Q4 | $217K | Sell |
6,324
-1,330,043
| -100% | -$45.4M | ﹤0.01% | 1896 |
|
|
2017
Q3 | $45.3M | Sell |
1,336,367
-230,826
| -15% | -$7.42M | 0.07% | 255 |
|
|
2017
Q2 | $49.9M | Buy |
1,567,193
+575,906
| +58% | +$18.2M | 0.09% | 208 |
|
|
2017
Q1 | $32.2M | Sell |
991,287
-50,908
| -5% | -$1.61M | 0.07% | 311 |
|
|
2016
Q4 | $32.1M | Buy |
1,042,195
+344,974
| +49% | +$10.5M | 0.07% | 306 |
|
|
2016
Q3 | $22.4M | Sell |
697,221
-558,198
| -44% | -$18.7M | 0.06% | 388 |
|
|
2016
Q2 | $41.9M | Buy |
1,255,419
+363,524
| +41% | +$11.6M | 0.12% | 197 |
|
|
2016
Q1 | $25.1M | Sell |
891,895
-227,558
| -20% | -$6.5M | 0.07% | 329 |
|
|
2015
Q4 | $34.3M | Buy |
1,119,453
+794,926
| +245% | +$25M | 0.08% | 273 |
|
|
2015
Q3 | $9.67M | Buy |
324,527
+210,379
| +184% | +$6.75M | 0.02% | 606 |
|
|
2015
Q2 | $3.63M | Sell |
114,148
-174,648
| -60% | -$5.69M | 0.01% | 926 |
|
|
2015
Q1 | $9.62M | Sell |
288,796
-1,212,838
| -81% | -$38.6M | 0.02% | 690 |
|
|
2014
Q4 | $44.4M | Buy |
1,501,634
+1,132,734
| +307% | +$32.5M | 0.09% | 234 |
|
|
2014
Q3 | $10.4M | Buy |
368,900
+129,010
| +54% | +$3.62M | 0.02% | 643 |
|
|
2014
Q2 | $6.75M | Buy |
239,890
+227,031
| +1,766% | +$6.47M | 0.01% | 746 |
|
|
2014
Q1 | $391K | Sell |
12,859
-2,108,421
| -99% | -$62.9M | ﹤0.01% | 1463 |
|
|
2013
Q4 | $61.6M | Buy |
2,121,280
+364,789
| +21% | +$10.6M | 0.16% | 135 |
|
|
2013
Q3 | $47.9M | Buy |
+1,756,491
| New | +$47.8M | 0.13% | 170 |
|
Other funds holding PFE
VCM
VPM
HSBC Holdings's PFE Position: Q1 2026 in Review
HSBC Holdings reduced its Pfizer (PFE) stake by 7.3% in Q1 2026, selling an estimated $31M and leaving 14,769,053 shares worth $414M. The position accounts for 0.22% of the portfolio, ranked #85.
HSBC Holdings first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $575M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- HSBC Holdings held 14,769,053 shares of Pfizer worth $414M as of Q1 2026.
- HSBC Holdings sold 1,165,180 Pfizer shares in Q1 2026, an estimated $31M.
- Pfizer made up 0.22% of HSBC Holdings's portfolio in Q1 2026, its #85 holding.
- HSBC Holdings first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Pfizer position peaked at $575M in Q4 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.